With a robust background in technology and healthcare investments, the fund manager has actively engaged in over 30 deals across North America and Europe. Their strategy emphasizes a data-driven approach, focusing on early to growth-stage companies. Noteworthy exits include successful partnerships with leading firms that enhanced portfolio value significantly. Committed to thematic investing, they leverage deep operational insights to identify high-potential opportunities in rapidly evolving markets.